methylguanidine has been researched along with niacinamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, BC; Lawley, PD | 1 |
| Chen, HI; Kao, SJ; Liu, DD; Su, CF | 1 |
2 other study(ies) available for methylguanidine and niacinamide
| Article | Year |
|---|---|
Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating agents.
Topics: 2-Acetylaminofluorene; Alkylating Agents; Animals; Benz(a)Anthracenes; Busulfan; Chromatography, Thin Layer; Cytarabine; Deoxycytidine; Dichlorvos; Dimethylnitrosamine; Ethyl Methanesulfonate; Female; Fluorouracil; Hydrocarbons, Brominated; Mechlorethamine; Methylguanidine; Niacinamide; Nitrosourea Compounds; Rats; Thymidine; Uric Acid | 1975 |
Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Disease Models, Animal; Free Radicals; Interleukin-1; Ischemia; Lung; Lung Injury; Male; Methylguanidine; Niacinamide; Nitric Oxide; Nitric Oxide Synthase; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2007 |